TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research ...

Vancouver, British Columbia--(Newsfile Corp. - March 3, 2025) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a ...

Detailed price information for Revive Therapeutics Ltd (RVV-CN) from The Globe and Mail including charting and trades.

SHANGHAI, March 26, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech developing innovative IL-2-independent Tumor-Infiltrating ...

ONCOTELIC THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS ...

Detailed price information for Rapid Dose Therapeutics Corp. (DOSE-CN) from The Globe and Mail including charting and trades.

"We are pleased to collaborate with Atossa Therapeutics to discover next-generation antibody therapies for breast cancer," said Jingsong Wang, M.D., Ph.D., Chairman of Nona Biosciences.

Our Killer50 companies traditionally enjoy a strong start to a new year. In 2024, nine companies (six in the Life Sciences segment) raised a collective $711m. The big winners then were quantum ...

SHANGHAI, March 31, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization ...

BEIJING, March 24, 2025 /PRNewswire/ -- SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today ...

Another recent development saw Avenzo Therapeutics, a California-based firm, entering into a license contract in January with ...

Amidst the backdrop of global trade tensions and economic policy shifts, Asian markets have shown resilience with mainland ...